Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer.
Int J Clin Oncol
; 2024 Jul 23.
Article
in En
| MEDLINE
| ID: mdl-39043985
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Int J Clin Oncol
Journal subject:
NEOPLASIAS
Year:
2024
Type:
Article
Affiliation country:
Japan